CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Saturn V Capital Management LP's Holding History (CIK: 0001964437)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 59,017 Value ($000) $1,979 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 59,125 Value ($000) $3,023 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 109,567 Value ($000) $5,599 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 479,681 Value ($000) $21,485 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 660,143 Value ($000) $30,901 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 787,132 Value ($000) $28,006 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 1,126,579 Value ($000) $33,504 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 938,677 Value ($000) $16,915 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 741,043 Value ($000) $11,901 Avg Close $18.51 Range $15.23 - $21.65
Q4 2022
Shares 623,819 Value ($000) $11,337 Avg Close $17.62 Range $15.37 - $19.97